Short Versus Standard Intramedullary Nail for Trochanteric Hip Fractures
NCT ID: NCT02680028
Last Updated: 2021-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
229 participants
INTERVENTIONAL
2015-11-30
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Recent randomised studies from Peterborough involving 1000 patients have indicated that there are modest benefits for treating this type of fracture with an intramedullary nail in comparison to a sliding hip screw. This study aims to progress from these earlier studies to determine if a slightly thinner and shorter intramedullary nail (175mm in length), has any significant advantages or disadvantages to the standard length (220mm) intramedullary nail.
Both implants to be used in this study are in routine use around the world and are being used within their licenced indication. The study is therefore using two different designs of implant within their recommended area of use, but in which there is uncertainty as to which is the best design.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nail Versus Sliding Hip Screw for Trochanteric Hip Fractures
NCT03172923
Hemiarthroplasty Versus Total Hip Replacement for Intracapsular Hip Fractures
NCT02998359
Cemented Hemiarthroplasty Versus Uncemented Furlong Hemiarthroplasty
NCT02998034
A Prospective Randomised Multicenter Study Comparing the Sliding Hip Screw and the Intertan Nail in Trochanteric and Subtrochanteric Femoral Fractures
NCT00621088
Intramedullary Nail Versus Hip Arthroplasty in Unstable Trochanteric Hip Fractures
NCT04868305
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In Peterborough all hip fracture patients are admitted to the acute trauma ward and transferred to the care of the Chief Investigator (Mr Martyn Parker (MJP)). Those patients that are willing to participant in this randomised trial are consented prior to surgery. Treatment follows standard evidence based protocols with follow-up of all patients in a hip fracture clinic. A comprehensive database is maintained for all patients containing both audit and research data. Included in this is a standardised assessment of outcome.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard length intramedullary nail
220mm intramedullary nail
targon pft nail
220 mm vs 175mm nail
Short length intramedullary nail
175mm intramedullary nail
targon pft nail
220 mm vs 175mm nail
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
targon pft nail
220 mm vs 175mm nail
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients admitted when MJP is not available to supervise treatment
* Patients with pathological fractures from Paget's disease of bone secondaries from tumour
* Patients with a Subtrochanteric fracture and those of the reversed and transverse fracture type (A3 fractures)
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peterborough and Stamford Hospitals NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Martyn J Parker
Consultant Orthopaedic Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
martyn parker
Role: PRINCIPAL_INVESTIGATOR
Peterborough hospital nhs trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peterbrough City Hospital
Peterborough, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Parker MJ, Cawley S. Short (175 mm) versus standard (220 mm) length intramedullary nail for trochanteric hip fractures: a randomized trial of 229 patients. Bone Joint J. 2020 Mar;102-B(3):394-399. doi: 10.1302/0301-620X.102B3.BJJ-2019-0776.R3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R&D/2015/28
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.